Company Filing History:
Years Active: 2008
Title: Keon Richard Glenn: Innovator in Plant-Based Chymosin Production
Introduction
Keon Richard Glenn is a notable inventor based in Calgary, Canada. He has made significant contributions to the field of biotechnology, particularly in the commercial production of chymosin. His innovative methods have the potential to impact the food industry positively.
Latest Patents
Glenn holds a patent for the "Commercial production of chymosin in plants." This patent describes a method for the recombinant expression of chymosin in plant seeds. The method enables chymosin to accumulate to at least 0.5% (w/w) of total seed protein. Additionally, an improved method for the isolation of chymosin from the seed is also detailed in the patent.
Career Highlights
Keon Richard Glenn is associated with Sembiosys Genetics, Inc., where he continues to advance his research and development efforts. His work focuses on innovative solutions that leverage plant biotechnology for commercial applications.
Collaborations
Glenn collaborates with talented individuals in his field, including Gijs Van Rooijen and Yin Shen. Their combined expertise contributes to the success of their projects and the advancement of biotechnological innovations.
Conclusion
Keon Richard Glenn is a pioneering inventor whose work in the commercial production of chymosin in plants showcases his commitment to innovation in biotechnology. His contributions are poised to make a lasting impact on the industry.